Epithalon

Description

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural peptide Epithalamin, extracted from the pineal gland. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, Epithalon has been the subject of over 100 published studies — most focused on its interaction with telomerase, the enzyme responsible for maintaining telomere length.

Research Profile

The central finding across Epithalon research: activation of telomerase in human somatic cells. A 2003 study in the Bulletin of Experimental Biology and Medicine demonstrated telomerase reactivation in human fetal fibroblasts and adult somatic cells treated with Epithalon, leading to telomere elongation beyond the Hayflick limit. Subsequent studies documented extended lifespan in animal models, improved melatonin cycling, and restoration of age-related neuroendocrine decline.

Key Research Areas

• Telomerase activation and telomere elongation
• Melatonin rhythm normalization in aging models
• Lifespan extension in multiple animal models
• Antioxidant enzyme regulation
• Neuroendocrine system restoration

Specifications

Sequence	Ala-Glu-Asp-Gly
Molecular Weight	390.35 g/mol
Purity	≥99% (HPLC verified)
Form	Lyophilized powder
Quantity	10mg per vial
Storage	-20°C / protect from light and moisture

Related Research Peptides

Epithalon is often studied alongside GHK-Cu in anti-aging research — addressing complementary pathways (telomere maintenance vs. gene expression remodeling). See Thymosin Alpha 1 for immune aging and our complete anti-aging peptides guide.

Research Dosage Protocols

Epithalon (Epitalon) research stems primarily from Dr. Vladimir Khavinson’s work at the St. Petersburg Institute of Bioregulation and Gerontology, where it was studied across multiple animal species and in limited human bioregulator trials. Animal longevity studies used doses of 0.1–1mg/kg via subcutaneous injection in daily or cycling protocols. A 10mg vial reconstituted in 2mL bacteriostatic water yields 5mg/mL. Russian clinical trials used total dose cycles of 20–30mg delivered over 10–20 days, repeated annually. Because most Western literature extrapolates from Russian-language publications, researchers should note that many protocols in English-language forums derive from translated sources and may lack primary citation.

Frequently Asked Questions

Who is Dr. Khavinson and why is his research central to Epithalon?

Vladimir Khavinson is a Russian gerontologist who has spent decades at the St. Petersburg Institute of Bioregulation and Gerontology studying short peptide bioregulators. He isolated and characterized Epithalon from bovine pineal gland tissue in the 1980s, and his group has published the majority of the primary research on Epithalon’s biological effects. The research spans rodent longevity studies (showing 20–30% lifespan extension in some models), telomerase activation data, antioxidant enzyme studies, and limited human trial data. Much of the foundational literature is in Russian-language journals, which has historically limited Western scientific uptake and peer review of the findings.

How does telomerase activation work, and how does Epithalon relate to it?

Telomerase is a ribonucleoprotein enzyme that adds repetitive TTAGGG sequences to the ends of chromosomes (telomeres) to compensate for the shortening that occurs with each cell division. Most somatic cells have low telomerase activity — telomeres shorten with age until they reach a critical minimum that triggers cell senescence. Epithalon has been reported to upregulate telomerase expression in cell culture and in some animal models, potentially slowing this attrition. The proposed mechanism involves Epithalon’s influence on epigenetic regulatory factors that control TERT (telomerase reverse transcriptase) gene expression, though the complete signaling pathway is not fully characterized.

What cycling protocols are used in Epithalon longevity research?

Khavinson’s group used two general protocols: a short intensive cycle (daily injections for 10–20 days, once or twice annually) and a longer maintenance approach (lower-dose injections multiple times weekly for extended periods). The intensive cycle protocol mirrors how other peptide bioregulators from his research group were administered in clinical contexts. Some Western researchers have adapted these to 1–2 annual cycles based on the available data. There is no head-to-head comparative study establishing which protocol produces superior telomere or longevity endpoints — the existing literature does not address this question directly.

How do I reconstitute Epithalon, and what are the storage requirements?

Epithalon (Ala-Glu-Asp-Gly) is a small tetrapeptide that dissolves easily. Add bacteriostatic water to the lyophilized vial — 2mL per 10mg vial gives 5mg/mL. Gently roll to dissolve; Epithalon typically dissolves in under 2 minutes. Refrigerate at 2–8°C after reconstitution; working stability is approximately 4–6 weeks. Lyophilized powder should be stored at -20°C for long-term retention. Epithalon is one of the more stable synthetic peptides due to its small size and relatively simple amino acid composition — it’s less prone to aggregation than amphipathic or disulfide-containing peptides.

What is Epithalon’s relationship to melatonin production?

Epithalon was originally isolated from pineal gland tissue, and Khavinson’s research documented its role in restoring melatonin secretion rhythms in aged animals. Melatonin production declines significantly with age, which is associated with disrupted circadian rhythms and reduced antioxidant defense. Studies in aging rats showed Epithalon administration restored pineal gland melatonin secretion toward levels seen in younger animals. Whether this is a direct effect on pinealocyte function or mediated through upstream neuroendocrine regulation isn’t fully established. This melatonin connection is one reason Epithalon is studied in sleep quality and circadian biology research contexts.

How does Epithalon compare to other longevity-focused research compounds?

Epithalon occupies a unique position in longevity research because of its direct telomerase activation data — few compounds have demonstrated this specific mechanism in published studies. Rapamycin (mTOR inhibition), NAD+ precursors (sirtuins), and metformin (AMPK pathway) address longevity mechanisms that don’t specifically target telomere dynamics. Klotho, FOXO pathways, and senolytics (clearing senescent cells) are parallel areas with different upstream targets. Epithalon’s pineal/melatonin angle also distinguishes it from purely metabolic longevity approaches. The research base is narrower and geographically concentrated compared to rapamycin or NAD+ literature, but the existing telomerase data remains a research niche Epithalon uniquely occupies.

For research and laboratory use only. Not for human consumption. All peptides are sold strictly as research chemicals.